共 751 条
[91]
Chang HJ(2019)Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain Int Immunopharmacol 38 1124-16
[92]
Han S-W(2019)The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: recent findings and new perspectives J Natl Cancer Inst 120 1463-9
[93]
Oh D-Y(2017)Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study Pharmacol Reports 10 694-20
[94]
Im S-A(2019)Sphingosine kinase 1/sphingosine-1-phosphate receptors dependent signalling in neurodegenerative diseases. The promising target for neuroprotection in Parkinson’s disease J Mol Neurosci 37 172-37
[95]
Bang Y-J(2014)S1P promotes inflammation-induced tube formation by HLECs via the S1PR1/NF-κB pathway Neurochem Res 160 S17-27
[96]
Johnson C(2018)The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy Mol Immunol 320 112958-17
[97]
Pankratz VS(2018)FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide J Neurosci 74 893-13
[98]
Velazquez AI(2014)Pharmacological manipulation of Trk, p75NTR, and NGF balance restores memory deficit in global ischemia/reperfusion model in rats Anesthesiology 6 28861-45
[99]
Aakre JA(2014)GM1 ganglioside activates ERK1/2 and Akt downstream of Trk tyrosine kinase and protects PC12 cells against hydrogen peroxide toxicity Nat Rev Neurol 96 e6-16
[100]
Loprinzi CL(2016)Ganglioside GM1 protects against high altitude cerebral edema in rats by suppressing the oxidative stress and inflammatory response via the PI3K/AKT-Nrf2 pathway Trends Pharmacol Sci 119 737-10